Related Experiment Video
Updated: May 2, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Desensitization by different strategies of epidermal growth factor receptor and ErbB4
Hideyuki Yamamoto1, Sayomi Higa-Nakamine, Nobuhiro Noguchi
1Department of Biochemistry, Graduate School of Medicine, University of the Ryukyus, Japan.
Abstract:
Four transmembrane tyrosine kinases constitute the ErbB protein family: epidermal growth factor receptor (EGFR) or ErbB1, ErbB2, ErbB3, and ErbB4. In general, the structure and mechanism of the activation of these members are similar. However, significant differences in homologous desensitization are known between EGFR and ErbB4. Desensitization of ligand-occupied EGFR occurs by endocytosis, while that of ErbB4 occurs by selective cleavage at the cell surface. Because ErbB4 is abundantly expressed in neurons from fetal to adult brains, elucidation of the desensitization mechanism is important to understand neuronal development and synaptic functions. Recently, it has become clear that heterologous desensitization of EGFR and ErbB4 are induced by endocytosis and cleavage, respectively, similar to homologous desensitization. It has been reported that heterologous desensitization of EGFR is induced by serine phosphorylation of EGFR via the p38 mitogen-activated protein kinase (p38 MAP kinase) pathway in various cell lines, including alveolar epithelial cells. In contrast, the protein kinase C pathway is involved in ErbB4 cleavage. In this review, we will describe recent advances in the desensitization mechanisms of EGFR and ErbB4, mainly in alveolar epithelial cells and hypothalamic neurons, respectively.
Insights
Epidermal growth factor receptor (EGFR) and ErbB4 desensitization differ; EGFR uses endocytosis, while ErbB4 undergoes cleavage. Understanding these distinct mechanisms is crucial for neuronal development and function.
Area of Science:
- Cellular Biology
- Neuroscience
- Molecular Biology
Background:
- The ErbB protein family, including EGFR and ErbB4, are transmembrane tyrosine kinases with similar activation mechanisms.
- Distinct homologous desensitization pathways exist: EGFR desensitizes via endocytosis, whereas ErbB4 desensitizes through cell-surface cleavage.
- ErbB4 is highly expressed in neurons, making its desensitization mechanism critical for understanding brain development and synaptic function.
Purpose of the Study:
- To review recent advances in understanding the desensitization mechanisms of EGFR and ErbB4.
- To highlight the differences in homologous and heterologous desensitization pathways for EGFR and ErbB4.
- To emphasize the importance of ErbB4 desensitization in neuronal contexts.
Main Methods:
- Review of existing literature on ErbB receptor desensitization.
- Focus on studies involving alveolar epithelial cells (for EGFR) and hypothalamic neurons (for ErbB4).
- Discussion of signaling pathways involved, including p38 MAP kinase and protein kinase C.
Main Results:
- Homologous desensitization of EGFR involves endocytosis, while ErbB4 involves selective cell-surface cleavage.
- Heterologous desensitization mirrors homologous pathways: EGFR via endocytosis and ErbB4 via cleavage.
- EGFR desensitization is linked to serine phosphorylation via the p38 MAP kinase pathway.
- ErbB4 cleavage is associated with the protein kinase C pathway.
Conclusions:
- EGFR and ErbB4 exhibit divergent desensitization mechanisms, impacting cellular responses.
- These distinct pathways are conserved in both homologous and heterologous desensitization.
- Elucidating these mechanisms provides insight into EGFR function in epithelial cells and ErbB4 function in neurons.
Related Concept Videos
Mitogens and the Cell Cycle
GPCR Desensitization
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Renewal of Skin Epidermal Stem Cells
Clinical Applications of Epidermal Stem Cells
Desensitization and Tachyphylaxis

